Buy Crypto Markets Spot FuturesETH Earn Event Center Rewards Hub

BioStem Technologies, Inc. (BSEM)

NASDAQ

$3.65

$+0.32

(+9.72%)

Market Closed

BioStem Technologies, Inc. (BSEM) Live Price Chart

Last updated: ⁦2026-08-21 05:10:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Key Market Data

Market Cap	$56.17M
Open	$3.51
High	$28.26
Low	$0.80
Previous Close	$3.35
Price Change	$+0.32
Percentage Change	+9.72%
Volume	150K

BioStem Technologies, Inc. (BSEM) Stock Price Today

BioStem Technologies, Inc. (BSEM) is currently trading at $3.65 as of 2026-08-20 23:46:00, reflecting a +9.72% move ($+0.32) from the previous close.

In the short term, the stock has returned -7.12% over the past four weeks. Over the last 12 months, BioStem Technologies, Inc. has recorded a -40.65% price change, indicating a Weak performance relative to the broader market.

BioStem Technologies, Inc. (BSEM) 7-Day Stock Price Changes

Over the past seven days, BioStem Technologies, Inc. has traded within a short-term range shaped by market sentiment in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. During this period, the stock moved from its previous closing price of $3.11 to the latest recorded price of $3.65, reflecting an intraday change of +9.72%. Daily movements highlight shifts in trading volume (149,840), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, BSEM has delivered a -7.12% return over the past month and a -40.65% change in the last 12 months, indicating a Weak trend relative to its broader sector peers.

How to Buy BioStem Technologies, Inc. (BSEM)

You can buy and trade BSEM on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for BSEM and Execute Your Trade

Open the trading page, enter BSEM in the search bar, select the amount of BSEM you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is BioStem Technologies, Inc. (BSEM)?

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

BioStem Technologies, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	2
Sector	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Company Website	https://www.biostemtechnologies.com

Frequently Asked Questions (FAQ)

1.What is the current share price of BioStem Technologies, Inc.?

The latest trading price for BioStem Technologies, Inc. (Common Stock) is $ 3.65, compared with a previous closing price of $ 3.35. That means the stock has moved +9.72% so far today. Intraday price updates and recent trading activity for BSEM can be tracked on the live chart and quote section on this page.

2.Is BioStem Technologies, Inc. stock going up or down?

Looking at recent performances, BSEM has returned -7.12% over the past month, -36.92% over the last six months and -40.65% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Weak price momentum for BioStem Technologies, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does BSEM currently sit relative to its 52-week high and low?

In the most recent 52-week period, BioStem Technologies, Inc. has traded between a low of $ 2.25 and a high of $ 8.40. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether BSEM is currently nearer the top or the bottom of its one-year trading band.

4.How is BioStem Technologies, Inc. classified by sector and industry?

BioStem Technologies, Inc. is classified in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. In practice, this means BioStem Technologies, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing BSEM’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector could influence BioStem Technologies, Inc.’s performance.

5.Where is BioStem Technologies, Inc. listed and how large is it by market value?

BioStem Technologies, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 56.17M, the company is classified as a Small-cap stock. Market cap gives a quick sense of BioStem Technologies, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does BSEM's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit BioStem Technologies, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track BioStem Technologies, Inc.'s financial performance over time?

To follow BioStem Technologies, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how BSEM is performing and how the market is responding.

8.When is BioStem Technologies, Inc. expected to report earnings?

BioStem Technologies, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for BSEM, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in BioStem Technologies, Inc.'s earnings reports?

BioStem Technologies, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether BSEM is meeting, beating or missing expectations.

10.How can I stay informed about BioStem Technologies, Inc.'s results and guidance?

You can stay up to date on BioStem Technologies, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for BSEM on this page helps you see how new information is being reflected in the stock.

11.Does BioStem Technologies, Inc. pay a regular cash dividend to its shareholders?

BioStem Technologies, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor BSEM's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for BSEM?

Based on the latest earnings data, BSEM has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether BioStem Technologies, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings BioStem Technologies, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is BioStem Technologies, Inc.?

BioStem Technologies, Inc. is a publicly traded company in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry within the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is BSEM valued in terms of P/E ratio and EPS?

BioStem Technologies, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of BioStem Technologies, Inc.'s earnings. Comparing BSEM's P/E and EPS to those of other BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Micron Technology, Inc.

Advanced Micro Devices

AMD

GE Aerospace

Top Gainers

Browse today's leading gainers in the US stock market

Werewolf Therapeutics, Inc.

Wetour Robotics Limited

WETO

Indaptus Therapeutics, Inc.

INDP

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

MEXC Aug 8: Share $500K

Refer friends early to earn 888% APR and $3,888

BSEM-to-USD Calculator

Amount

BSEM

USD

1 BSEM = 3.65 USD